147 related articles for article (PubMed ID: 31465596)
61. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
Alexiades-Armenakas M
J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
[TBL] [Abstract][Full Text] [Related]
62. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma.
Walling HW; Scupham RK; Bean AK; Ceilley RI
J Am Acad Dermatol; 2007 Oct; 57(4):659-64. PubMed ID: 17870430
[TBL] [Abstract][Full Text] [Related]
63. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M
Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388
[TBL] [Abstract][Full Text] [Related]
64. Lentigo maligna: review of salient characteristics and management.
Kallini JR; Jain SK; Khachemoune A
Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
[TBL] [Abstract][Full Text] [Related]
65. Lentigo maligna : prognosis and treatment options.
Stevenson O; Ahmed I
Am J Clin Dermatol; 2005; 6(3):151-64. PubMed ID: 15943492
[TBL] [Abstract][Full Text] [Related]
66. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
[TBL] [Abstract][Full Text] [Related]
67. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience.
Bhardwaj SS; Tope WD; Lee PK
Dermatol Surg; 2006 May; 32(5):690-6; discussion 696-7. PubMed ID: 16706765
[TBL] [Abstract][Full Text] [Related]
68. Short incubation fractional CO
Vrani F; Sotiriou E; Lazaridou E; Vakirlis E; Sideris N; Kirmanidou E; Apalla Z; Lallas A; Ioannides D
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):79-83. PubMed ID: 29869444
[TBL] [Abstract][Full Text] [Related]
69. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
Swetter SM; Chen FW; Kim DD; Egbert BM
J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
[TBL] [Abstract][Full Text] [Related]
70. Epidemiology of Lentigo Maligna and Lentigo Maligna Melanoma in the Netherlands, 1989-2013.
Greveling K; Wakkee M; Nijsten T; van den Bos RR; Hollestein LM
J Invest Dermatol; 2016 Oct; 136(10):1955-1960. PubMed ID: 27349862
[TBL] [Abstract][Full Text] [Related]
71. Efficacy of iontophoresis-assisted ablative fractional laser photodynamic therapy with short incubation time for the treatment of actinic keratosis: 12-month follow-up results of a prospective, randomised, comparative trial.
Choi SH; Kim TH; Song KH
Photodiagnosis Photodyn Ther; 2017 Jun; 18():105-110. PubMed ID: 28167201
[TBL] [Abstract][Full Text] [Related]
72. Surgical and histologic pitfalls in the management of lentigo maligna melanoma.
Situm M; Buljan M
G Ital Dermatol Venereol; 2012 Feb; 147(1):21-7. PubMed ID: 22370566
[TBL] [Abstract][Full Text] [Related]
73. Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma.
Smucler R; Vlk M
Lasers Surg Med; 2008 Feb; 40(2):153-8. PubMed ID: 18306163
[TBL] [Abstract][Full Text] [Related]
74. Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
Kai AC; Richards T; Coleman A; Mallipeddi R; Barlow R; Craythorne EE
Br J Dermatol; 2016 Jan; 174(1):165-8. PubMed ID: 26595446
[TBL] [Abstract][Full Text] [Related]
75. Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study.
Ahlgrimm-Siess V; Massone C; Scope A; Fink-Puches R; Richtig E; Wolf IH; Koller S; Gerger A; Smolle J; Hofmann-Wellenhof R
Br J Dermatol; 2009 Dec; 161(6):1307-16. PubMed ID: 19566662
[TBL] [Abstract][Full Text] [Related]
76. 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
Räsänen JE; Neittaanmäki N; Ylitalo L; Hagman J; Rissanen P; Ylianttila L; Salmivuori M; Snellman E; Grönroos M
Br J Dermatol; 2019 Aug; 181(2):265-274. PubMed ID: 30329163
[TBL] [Abstract][Full Text] [Related]
77. Surgical treatments for lentigo maligna: a review.
McLeod M; Choudhary S; Giannakakis G; Nouri K
Dermatol Surg; 2011 Sep; 37(9):1210-28. PubMed ID: 21631635
[TBL] [Abstract][Full Text] [Related]
78. Lentigo maligna melanoma.
Price L
Dermatol Nurs; 2004 Oct; 16(5):454. PubMed ID: 15624713
[No Abstract] [Full Text] [Related]
79. Staged margin-controlled excision (SMEX) for lentigo maligna melanoma in situ.
Beveridge J; Taher M; Zhu J; Mahmood MN; Salopek TG
J Surg Oncol; 2018 Jul; 118(1):144-149. PubMed ID: 29936706
[TBL] [Abstract][Full Text] [Related]
80. Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna.
Bassukas ID; Gamvroulia C; Zioga A; Nomikos K; Fotika C
Int J Dermatol; 2008 May; 47(5):519-21. PubMed ID: 18412875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]